19 May 2013
Keywords: msd, withdraws, ma, vorinostat, eu, merck, sharp
Article | 23 February 2009
Merck Sharp & Dohme, the UK subsidiary of US drug major Merck & Co, has withdrawn its application for a centralized marketing ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 February 2009
16 February 2009
17 May 2013
© 2013 thepharmaletter.com